Search hospitals > Connecticut > New Haven

Yale University

Claim this profile
New Haven, Connecticut 06510
Global Leader in Skin Cancer
Global Leader in Cancer
Conducts research for Uterine Tumors
Conducts research for Relapse
Conducts research for Breast Cancer
1112 reported clinical trials
192 medical researchers
Photo of Yale University in New HavenPhoto of Yale University in New HavenPhoto of Yale University in New Haven

Summary

Yale University is a medical facility located in New Haven, Connecticut. This center is recognized for care of Skin Cancer, Cancer, Uterine Tumors, Relapse, Breast Cancer and other specialties. Yale University is involved with conducting 1,112 clinical trials across 1,690 conditions. There are 192 research doctors associated with this hospital, such as Nina S. Kadan-Lottick, Farzana Pashankar, Patricia M Lorusso, and Alessandro Santin.

Area of expertise

1Skin Cancer
Global Leader
Yale University has run 172 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Cancer
Global Leader
Yale University has run 111 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I

Top PIs

Clinical Trials running at Yale University

Breast Cancer
Lung Cancer
Skin Cancer
Multiple Myeloma
Small Cell Lung Cancer
Testicular cancer
Breast cancer
Pancreatic Cancer
Plasma Cell Neoplasm
Non-Small Cell Lung Cancer
Image of trial facility.

Sacituzumab Tirumotecan + Pembrolizumab

for Breast Cancer

Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer (TNBC). The main goal of this study is to learn if people treated with sacituzumab tirumotecan alone or with pembrolizumab live longer overall or without the cancer growing or spreading compared to people treated with chemotherapy.
Recruiting2 awards Phase 33 criteria
Image of trial facility.

Imlunestrant

for Early Breast Cancer

This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Yale University?
Where is Yale University located?
Who should I call to ask about financial aid or insurance network?
What insurance does Yale University accept?
What awards or recognition has Yale University received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security